Clinical Trial Update: CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a CAR-T cell therapy for untreated high-risk mantle cell lymphoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: Christian Schmidt, MD | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: RECRUITING